ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

caBIG Architect Kenneth Buetow Resigns

December 16, 2011

Six Centers Win Grants

July 11, 2003

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002

Interview: Joseph Jacobs Claims “Political Extortion” By The “Harkinites”

October 14, 1994